{"title":"HIV药物商标案在英国被移交。","authors":"Jennifer Gold","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>A United Kingdom (UK) court has ruled that that the diversion to, and sale in, the UK of antiretroviral medications destined for Africa infringed the patents of Glaxo Group Ltd.</p>","PeriodicalId":83647,"journal":{"name":"Canadian HIV/AIDS policy & law review","volume":"8 3","pages":"58-9"},"PeriodicalIF":0.0000,"publicationDate":"2003-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"HIV drug trademark case handed down in UK.\",\"authors\":\"Jennifer Gold\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>A United Kingdom (UK) court has ruled that that the diversion to, and sale in, the UK of antiretroviral medications destined for Africa infringed the patents of Glaxo Group Ltd.</p>\",\"PeriodicalId\":83647,\"journal\":{\"name\":\"Canadian HIV/AIDS policy & law review\",\"volume\":\"8 3\",\"pages\":\"58-9\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2003-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Canadian HIV/AIDS policy & law review\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian HIV/AIDS policy & law review","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
A United Kingdom (UK) court has ruled that that the diversion to, and sale in, the UK of antiretroviral medications destined for Africa infringed the patents of Glaxo Group Ltd.